What is the accuracy of Hitachi's AI technology for diagnosing 16 classes of hematological malignancies?

Hitachi's AI technology achieved an accuracy of AUC 0.9 or higher in diagnosing 16 classes of hematological malignancies.

How many clinical cases were used to evaluate the performance of Kyushu University Hospital's AI diagnostic tool?

Over 500 clinical cases were used to evaluate the performance of Kyushu University Hospital's AI diagnostic tool.

Which medical institution collaborated with Hitachi on the development of the AI-based differential diagnosis system in 2023?

Kyushu University Hospital collaborated with Hitachi on the development of the AI-based differential diagnosis system in 2023.

What type of data does Hitachi's AI technology use from flow cytometry testing for leukemia diagnosis?

Hitachi's AI technology uses marker positivity rates from flow cytometry testing data for leukemia diagnosis.

AI News NQ Analysis

Development of AI Technology to Support Differential Diagnosis of Hematological Malignancies

NQ Score 97/100

N1 Content Completeness 5

AI Summary (NQ-processed)

Hitachi and Kyushu University Hospital have developed machine learning-based AI technology to support differential diagnosis of hematological malignancies. The technology uses marker positivity rates from flow cytometry (FCM) testing data as features to provide probability-based candidate diseases for 16 classes, including leukemia, lymphoma, and multiple myeloma. Accuracy of AUC 0.9 or higher was confirmed in evaluations using over 500 clinical cases. Future plans involve implementation through joint verification (PoC) with medical institutions.

AI Analysis

Frequently Asked Questions

Q: What is the accuracy of Hitachi's AI technology for diagnosing 16 classes of hematological malignancies?: A: Hitachi's AI technology achieved an accuracy of AUC 0.9 or higher in diagnosing 16 classes of hematological malignancies.
Q: How many clinical cases were used to evaluate the performance of Kyushu University Hospital's AI diagnostic tool?: A: Over 500 clinical cases were used to evaluate the performance of Kyushu University Hospital's AI diagnostic tool.
Q: Which medical institution collaborated with Hitachi on the development of the AI-based differential diagnosis system in 2023?: A: Kyushu University Hospital collaborated with Hitachi on the development of the AI-based differential diagnosis system in 2023.
Q: What type of data does Hitachi's AI technology use from flow cytometry testing for leukemia diagnosis?: A: Hitachi's AI technology uses marker positivity rates from flow cytometry testing data for leukemia diagnosis.
Q: What is the planned next step for implementing the AI technology developed by Hitachi and Kyushu University Hospital?: A: The planned next step is implementation through joint verification (PoC) with medical institutions.